PET-CT对肺癌放疗疗效的评价(4)
[28]Sironi S , Messa C , Mangili G, et al .Integrated FDG PET/ CT in patient swit hpersistent ovarian cancer : correlation with histologic findings [J].Radiology,2004,233(2):433-440.
[29]Delbeke D,Martin WH. PET and PET/CT for evaluation of colorectal carcinoma[J].Semin Nucl Med ,2004 ,34 ( 3) : 209-223.
[30]Patz EF, Connolly J, Herndon J. Prognostic value of thoracic FDG PET imaging after in non-small cell lung cancer[J].AJR 2000, 174(3):769-774.
[31]Dhital K, Saunders CA , Seed PT , et al . [(18)F] Fluorodeoxy glucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg , 2000 ,18(4) :425-428.
[32]Higashi K, Ueda Y, Arisaka Y, et al .18F FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non small cell lung cancer. J Nucl Med ,2002 ,43(1):39-45.
[33] Vansteenkiste JF , Stroobants SG, De Leyn PR , et al . Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa non-small cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. Ann Oncol,1998 ,9 (11) :1193-1198.
[34]Ryu JS , Choi NC , Fischman AJ , et al. FDG PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy : correlation with histopathology. Lung Cancer , 2002 , 35 (2) :179-187.
[35]Weber WA ,Petersen V,Schmidt B,et al. Positron emission tomography in non-small cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol , 2003 ,21(14) :2651-2657.
[36]Steinert HC. PET in lung cancer[J]. Chang Gung Med J ,2005 ,28 :296 - 305.
[37]徐本华，赵献光，钱明等. PET在肺癌诊断及治疗中的应用[J].国外医学肿瘤学分册2004，31(8)：615-618
[38]宋吉清,张成琪,陈静等.18 F-FDG PET-CT 在肺癌疗效监测中的临床应用价值[J]. 医学影像学杂志2006，16(2)：113-115, http://www.100md.com(张铭)
[29]Delbeke D,Martin WH. PET and PET/CT for evaluation of colorectal carcinoma[J].Semin Nucl Med ,2004 ,34 ( 3) : 209-223.
[30]Patz EF, Connolly J, Herndon J. Prognostic value of thoracic FDG PET imaging after in non-small cell lung cancer[J].AJR 2000, 174(3):769-774.
[31]Dhital K, Saunders CA , Seed PT , et al . [(18)F] Fluorodeoxy glucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg , 2000 ,18(4) :425-428.
[32]Higashi K, Ueda Y, Arisaka Y, et al .18F FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non small cell lung cancer. J Nucl Med ,2002 ,43(1):39-45.
[33] Vansteenkiste JF , Stroobants SG, De Leyn PR , et al . Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa non-small cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. Ann Oncol,1998 ,9 (11) :1193-1198.
[34]Ryu JS , Choi NC , Fischman AJ , et al. FDG PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy : correlation with histopathology. Lung Cancer , 2002 , 35 (2) :179-187.
[35]Weber WA ,Petersen V,Schmidt B,et al. Positron emission tomography in non-small cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol , 2003 ,21(14) :2651-2657.
[36]Steinert HC. PET in lung cancer[J]. Chang Gung Med J ,2005 ,28 :296 - 305.
[37]徐本华，赵献光，钱明等. PET在肺癌诊断及治疗中的应用[J].国外医学肿瘤学分册2004，31(8)：615-618
[38]宋吉清,张成琪,陈静等.18 F-FDG PET-CT 在肺癌疗效监测中的临床应用价值[J]. 医学影像学杂志2006，16(2)：113-115, http://www.100md.com(张铭)